Skip to search formSkip to main contentSkip to account menu

oral lichenoid reaction

Known as: lichenoid oral reactions 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Short‐term mucocutaneous adverse effects are well documented with imatinib. However, studies on long‐term adverse effects and in… 
Review
2015
Review
2015
Oral lichen planus (OLP) and oral lichenoid reaction (OLR) are clinically and histopathologically similar diseases. Whereas OLP… 
2015
2015
The aim of this article was to compare the expression of p53 protein in oral lichen planus (OLP) and oral lichenoid reaction (OLR… 
2014
2014
BACKGROUND Chronic inflammation causes disturbances in the lipid metabolism. When this dyslipidemia becomes prolonged it… 
2012
2012
Imatinib mesylate (IM) is a phenylaminopyrimidine that represents the first‐line treatment for chronic myeloid leukemia (CML… 
2011
2011
Recent attention has been directed toward the role of mast cells in the pathogenesis of oral lichen planus. Mast cells are… 
2010
2010
Abstract Background. Oral Lichen Planus (OLP) is an inflammatory disease of unknown etiology while Oral Lichenoid Reaction (OLR… 
Review
2009
Review
2009
Lichen planus (LP) is a mucocutaneous disease with well-established clinical and microscopic features. The oral mucosa and skin…